This inventor holds 3 USPTO granted patents and 8 published patent applications. Top assignee: Jubilant Draximage Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Vijayaraj Kuniyil Kulangara
Introduction
Vijayaraj Kuniyil Kulangara is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of radiopharmaceuticals, with a focus on enhancing safety and efficacy in medical applications. His work has led to the development of innovative systems and compounds that are crucial for diagnosis and therapy.
Latest Patents
Vijayaraj holds 3 patents that showcase his expertise and innovative spirit. His latest patents include:
1. **Systems for radioisotope generation and methods of preparation and administration**: This invention provides a radioisotope generator system with enhanced safety features. It includes a robust design comprising three ports: an evacuation port, a loading port, and a saline flush port. The design minimizes wastage of Mo-99 and ensures improved safety from needle contamination.
2. **Radiopharmaceutical conjugate compound for diagnosis and/or therapeutic uses thereof**: This patent presents a conjugate compound that includes a nanoparticulated enhanced permeability and retention (EPR) agent, which is an albumin. It is conjugated with various agents for targeted therapy and diagnosis, particularly in cancer treatment.
Career Highlights
Vijayaraj is currently associated with Jubilant Draximage Inc., where he continues to innovate in the field of radiopharmaceuticals. His work is characterized by a commitment to improving medical technologies and patient safety.
Collaborations
He collaborates with talented professionals such as Indranil Nandi and Miriam Ruiz Pena, contributing to a dynamic research environment that fosters innovation.
Conclusion
Vijayaraj Kuniyil Kulangara's contributions to the field of radiopharmaceuticals exemplify the impact of innovative thinking in medicine. His patents reflect a dedication to enhancing safety and efficacy in medical treatments, making a significant difference in patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile